135 related articles for article (PubMed ID: 19018457)
1. Improved methods for testing antiresorptive compounds in human osteoclast cultures.
Rissanen JP; Ylipahkala H; Fagerlund KM; Long C; Väänänen HK; Halleen JM
J Bone Miner Metab; 2009; 27(1):105-9. PubMed ID: 19018457
[TBL] [Abstract][Full Text] [Related]
2. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.
Rissanen JP; Suominen MI; Peng Z; Halleen JM
Calcif Tissue Int; 2008 Feb; 82(2):108-15. PubMed ID: 18084692
[TBL] [Abstract][Full Text] [Related]
3. A Novel Sandwich ELISA for Tartrate-Resistant Acid Phosphatase 5a and 5b Protein Reveals that Both Isoforms are Secreted by Differentiating Osteoclasts and Correlate to the Type I Collagen Degradation Marker CTX-I In Vivo and In Vitro.
Mira-Pascual L; Patlaka C; Desai S; Paulie S; Näreoja T; Lång P; Andersson G
Calcif Tissue Int; 2020 Feb; 106(2):194-207. PubMed ID: 31654098
[TBL] [Abstract][Full Text] [Related]
4. Rapid screening method for osteoclast differentiation in vitro that measures tartrate-resistant acid phosphatase 5b activity secreted into the culture medium.
Alatalo SL; Halleen JM; Hentunen TA; Mönkkönen J; Väänänen HK
Clin Chem; 2000 Nov; 46(11):1751-4. PubMed ID: 11067809
[TBL] [Abstract][Full Text] [Related]
5. An in vitro model for discovery of osteoclast specific biomarkers towards identification of racehorses at risk for catastrophic fractures.
Malek G; Richard H; Beauchamp G; Laverty S
Equine Vet J; 2023 May; 55(3):534-550. PubMed ID: 35616632
[TBL] [Abstract][Full Text] [Related]
6. Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast quality.
Neutzsky-Wulff AV; Sørensen MG; Kocijancic D; Leeming DJ; Dziegiel MH; Karsdal MA; Henriksen K
BMC Musculoskelet Disord; 2010 Jun; 11():109. PubMed ID: 20515459
[TBL] [Abstract][Full Text] [Related]
7. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
[TBL] [Abstract][Full Text] [Related]
8. [The effect of ferric ion on the differentiation of osteoclast and bone resorption].
Jia P; He YF; Gao C; Du HB; Hu ZY; Feng XQ; Li BY; Zhang ZL; Xu YJ; Lin H
Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2214-8. PubMed ID: 23158430
[TBL] [Abstract][Full Text] [Related]
9. Gingival fibroblasts are better at inhibiting osteoclast formation than periodontal ligament fibroblasts.
de Vries TJ; Schoenmaker T; Wattanaroonwong N; van den Hoonaard M; Nieuwenhuijse A; Beertsen W; Everts V
J Cell Biochem; 2006 May; 98(2):370-82. PubMed ID: 16440316
[TBL] [Abstract][Full Text] [Related]
10. Osteoclasts prefer aged bone.
Henriksen K; Leeming DJ; Byrjalsen I; Nielsen RH; Sorensen MG; Dziegiel MH; Martin TJ; Christiansen C; Qvist P; Karsdal MA
Osteoporos Int; 2007 Jun; 18(6):751-9. PubMed ID: 17216130
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
Kobayashi K; Takahashi N; Jimi E; Udagawa N; Takami M; Kotake S; Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Morinaga T; Higashio K; Martin TJ; Suda T
J Exp Med; 2000 Jan; 191(2):275-86. PubMed ID: 10637272
[TBL] [Abstract][Full Text] [Related]
12. Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating.
Greiner S; Kadow-Romacker A; Schmidmaier G; Wildemann B
J Biomed Mater Res A; 2009 Oct; 91(1):288-95. PubMed ID: 18980195
[TBL] [Abstract][Full Text] [Related]
13. A novel culture system to generate osteoclasts and bone resorption using porcine bone marrow cells: role of M-CSF.
Scheven BA; Milne JS; Robins SP
Biochem Biophys Res Commun; 1997 Feb; 231(1):231-5. PubMed ID: 9070255
[TBL] [Abstract][Full Text] [Related]
14. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
16. (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts.
Perez-Amodio S; Beertsen W; Everts V
J Bone Miner Res; 2004 Oct; 19(10):1722-31. PubMed ID: 15355568
[TBL] [Abstract][Full Text] [Related]
17. Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts.
Woo JT; Nakagawa H; Notoya M; Yonezawa T; Udagawa N; Lee IS; Ohnishi M; Hagiwara H; Nagai K
Biol Pharm Bull; 2004 Apr; 27(4):504-9. PubMed ID: 15056855
[TBL] [Abstract][Full Text] [Related]
18. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine affects bone resorption both in vitro and in vivo.
Both T; Zillikens MC; Schreuders-Koedam M; Vis M; Lam WK; Weel AEAM; van Leeuwen JPTM; van Hagen PM; van der Eerden BCJ; van Daele PLA
J Cell Physiol; 2018 Feb; 233(2):1424-1433. PubMed ID: 28556961
[TBL] [Abstract][Full Text] [Related]
20. A feline assay using osteoclasts generated in vitro from peripheral blood for screening anti-resorptive agents.
Muzylak M; Flanagan AM; Ingham K; Gunn N; Price J; Horton MA
Res Vet Sci; 2002 Dec; 73(3):283-90. PubMed ID: 12443687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
